Follow
Gene and Cell Therapy
With the goal of treating and curing disease, gene and cell therapy provide treatment by means of altering a person's genetic code and transferring live cells to improve symptoms and reduce levels of disease-causing proteins.
-
MAR 26, 2024 | 7:00 PMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher ScientificMAR 26, 2024 | 8:00 AMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher ScientificMARCH 22, 2024 3:30 PM ET
Cellular and gene-based therapeutic approaches are the future of medicine for many conditions. As the CGT field expands and deepens, the need for consistent and reliable partners becomes cri...Speaker: Mike MoellerDEC 05, 2023 | 8:00 AM
CGX10 Cell Isolation System: Introduction, Utility, and Assessment in a GMP-grade Environment for Multiparametric Cell Sorting A future of long-term, minimally toxic immunotherapy personaliz...NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...NOV 09, 2023 | 6:00 AM
In this talk we will explore the application of Multiplexed Error-Robust Fluorescence in situ Hybridization (MERFISH) technology to decode spatially regulated disease drivers in human heart...NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...OCT 31, 2023 | 9:00 AM
Gene therapy holds potential for treating neurological diseases by delivering genetic information into specific cell types. However, selective and efficient targeting of cell types remains c...OCT 24, 2023 | 9:00 PM
This webinar is hosted by Thermo Fisher Scientific in collaboration with the Walter and Eliza Hall Institute of Medical Research (WEHI). The webinar aims to demonstrate the benefits of the E...OCT 24, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...OCT 10, 2023 | 10:00 AMC.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...OCTOBER 05, 2023 2:00 PM ET
In this session we will help you gain an understanding of a Class II BSC's role in the rapidly growing cell and gene therapy market. We will cover......Speaker: Elizabeth Dille , David WaseschaSEP 26, 2023 | 8:00 AM
Join us for an educational webinar that delves into the fascinating world of Extracellular Vesicles (EVs) and their impact on biomedical research and medicine. In collaboration with ExoVecto...Speaker: Roland Leathers, PhD , Jeroen de Vrij, PhDSponsored By: Thermo Fisher Scientific/GibcoSEP 19, 2023 | 8:00 AMC.E. CREDITS
Success stories in the field of cell therapies are making headlines on a daily basis. These achievements involve complex manufacturing processes in which cytokines play a key role. Choosing...SEP 12, 2023 | 10:00 AM
Register to learn more about how to rapidly and reproducibly drive your developmental efforts forward by leveraging MaxCyte’s flow electroporation technology. Labs adopt this scalable...SEP 06, 2023 | 8:00 AM
The expansion and persistence of CAR T cells within patients is the key to a successful treatment. Therefore, monitoring of CD19 CAR T cells following infusion is of utmost interest. The CAR...Speaker: Dr. Annika Graband , Dr. Sabine Hünecke , Dr. Melanie BremmSponsored By: Miltenyi BiotecAUG 30, 2023 | 8:00 AM
In this third and final part of our translational cell and gene therapy webinar series we delve into cell therapy applications beyond immune oncology. Firstly, we will look into Miltenyi Bio...Speaker: Dr. Viola Stella Palladino , Kirsten Langeveld , Dr. Chao ShengSponsored By: Miltenyi BiotecAUG 16, 2023 | 8:00 AM
Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR T-cell therapies – from basic research to process development and clinical manufacturing. Discover the p...Speaker: Dr. Annika Graband , Dr. Melanie Rietenbach , Dr. Saskia RöschSponsored By: Miltenyi BiotecJUL 26, 2023 | 3:10 PMC.E. CREDITS
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
JUL 26, 2023 | 1:50 PM
C.E. CREDITS
The use of adeno-associated viruses (AAV) as gene delivery vectors has vast potential for the treatment of many severe human diseases. A small group of intensively studied AAV capsids have b...
JUL 26, 2023 | 12:15 PM
C.E. CREDITS
Genetically modified cell models accelerate the development of safe and effective therapeutics, making them indispensable in the quest for new drugs. Through manipulation of cell line geneti...
JUL 26, 2023 | 11:20 AM
C.E. CREDITS
Chimeric antigen receptor (CAR)-reprogrammed immune cells offer exciting therapeutic potential for addressing oncology, autoimmune diseases, transplant medicine, and infections. However, cur...
Speaker:
Dr. Dimitrios L. Wagner
Presented at: GenScript 3rd Annual Gene and Cell Engineering Summit
JUL 18, 2023 | 12:00 PM
While HSC research holds immense potential for regenerative medicine and disease treatment, the field poses significant challenges. Successful isolation and purification — and the abil...
JUN 15, 2023 | 10:00 AM
C.E. CREDITS
Insights gained from studies using genome editing tools can provide a better understanding of cellular physiology, so that we can uncover answers to complex diseases and ultimately develop t...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
MARCH 22, 2024 3:30 PM ET
Cellular and gene-based therapeutic approaches are the future of medicine for many conditions. As the CGT field expands and deepens, the need for consistent and reliable partners becomes cri...
Speaker:
Mike Moeller
DEC 05, 2023 | 8:00 AM
CGX10 Cell Isolation System: Introduction, Utility, and Assessment in a GMP-grade Environment for Multiparametric Cell Sorting A future of long-term, minimally toxic immunotherapy personaliz...
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 09, 2023 | 6:00 AM
In this talk we will explore the application of Multiplexed Error-Robust Fluorescence in situ Hybridization (MERFISH) technology to decode spatially regulated disease drivers in human heart...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 31, 2023 | 9:00 AM
Gene therapy holds potential for treating neurological diseases by delivering genetic information into specific cell types. However, selective and efficient targeting of cell types remains c...
OCT 24, 2023 | 9:00 PM
This webinar is hosted by Thermo Fisher Scientific in collaboration with the Walter and Eliza Hall Institute of Medical Research (WEHI). The webinar aims to demonstrate the benefits of the E...
OCT 24, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 10, 2023 | 10:00 AM
C.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
OCTOBER 05, 2023 2:00 PM ET
In this session we will help you gain an understanding of a Class II BSC's role in the rapidly growing cell and gene therapy market. We will cover......
Speaker:
Elizabeth Dille
, David Wasescha
SEP 26, 2023 | 8:00 AM
Join us for an educational webinar that delves into the fascinating world of Extracellular Vesicles (EVs) and their impact on biomedical research and medicine. In collaboration with ExoVecto...
Speaker:
Roland Leathers, PhD
, Jeroen de Vrij, PhD
Sponsored By: Thermo Fisher Scientific/Gibco
SEP 19, 2023 | 8:00 AM
C.E. CREDITS
Success stories in the field of cell therapies are making headlines on a daily basis. These achievements involve complex manufacturing processes in which cytokines play a key role. Choosing...
SEP 12, 2023 | 10:00 AM
Register to learn more about how to rapidly and reproducibly drive your developmental efforts forward by leveraging MaxCyte’s flow electroporation technology. Labs adopt this scalable...
SEP 06, 2023 | 8:00 AM
The expansion and persistence of CAR T cells within patients is the key to a successful treatment. Therefore, monitoring of CD19 CAR T cells following infusion is of utmost interest. The CAR...
Speaker:
Dr. Annika Graband
, Dr. Sabine Hünecke
, Dr. Melanie Bremm
Sponsored By: Miltenyi Biotec
AUG 30, 2023 | 8:00 AM
In this third and final part of our translational cell and gene therapy webinar series we delve into cell therapy applications beyond immune oncology. Firstly, we will look into Miltenyi Bio...
Speaker:
Dr. Viola Stella Palladino
, Kirsten Langeveld
, Dr. Chao Sheng
Sponsored By: Miltenyi Biotec
AUG 16, 2023 | 8:00 AM
Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR T-cell therapies – from basic research to process development and clinical manufacturing. Discover the p...
Speaker:
Dr. Annika Graband
, Dr. Melanie Rietenbach
, Dr. Saskia Rösch
Sponsored By: Miltenyi Biotec
JUL 26, 2023 | 3:10 PM
C.E. CREDITS
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
JUL 26, 2023 | 1:50 PM
C.E. CREDITS
The use of adeno-associated viruses (AAV) as gene delivery vectors has vast potential for the treatment of many severe human diseases. A small group of intensively studied AAV capsids have b...
JUL 26, 2023 | 12:15 PM
C.E. CREDITS
Genetically modified cell models accelerate the development of safe and effective therapeutics, making them indispensable in the quest for new drugs. Through manipulation of cell line geneti...
JUL 26, 2023 | 11:20 AM
C.E. CREDITS
Chimeric antigen receptor (CAR)-reprogrammed immune cells offer exciting therapeutic potential for addressing oncology, autoimmune diseases, transplant medicine, and infections. However, cur...
Speaker:
Dr. Dimitrios L. Wagner
Presented at: GenScript 3rd Annual Gene and Cell Engineering Summit
JUL 18, 2023 | 12:00 PM
While HSC research holds immense potential for regenerative medicine and disease treatment, the field poses significant challenges. Successful isolation and purification — and the abil...
JUN 15, 2023 | 10:00 AM
C.E. CREDITS
Insights gained from studies using genome editing tools can provide a better understanding of cellular physiology, so that we can uncover answers to complex diseases and ultimately develop t...